6Norris A,Todd C, Graham A, et al. The expression of the c-kit receptor by epidermal melanoytes may be reduced in vitiligo [ J ] Br J Dermatol, 1996,134 (2) : 299-306.
5OGG GS, ROD DUNBAR P, ROMERO P, et al. High frequency of skin-homing melanocyte - specific cytotoxic T lymphocytes in autoimmune vitiligo[J]. J Exp Med, 1998, 188(6) : 1203 -1208.
6WESTERHOF W, GROOT I, KRIEG SR, et al. Langerhans cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation [J]. Acta Derm Vemereol, 1986, 66(3) : 259 -262.
7KAO CHAO HSING, et al. Depletion and repopulation of Langerhans cells in nonsegraental type vitiligo[ J ]. J Dermatol, 1990, 17 (5) : 287 - 296.
8DAS PK, WIJNGAARD R, WANKOWICZ KA, et al. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo [J]. Trends Immunol, 2001, 22(3): 130-136.
9Gilhara,Aizenf,Ohanan,et al.Vitiliginous vs pigmented skin response to intrademal administration ofintorferon gamma[J].Arch Dermatol,1993,129 (5):600-604.
10Shevach EM.Certified professionals:CD4+CD25+ suppressor T cells[J].J Exp Med 2001,193(11):F41-46.
6William DJ, Timothy B, Dirk E. Andrews' Disease of the skin [ M ]. The tenth edition. USA : Elsvier, 2006 : 160.
7Cevc G, Gebauer D, Stieber J, et al. Ultraflexible vesi- cles, Transfersomes, have an extremely low pore penetra- tion resistance and transport therapeutic amounts of insu- lin across the intact mammalian skin [ J ]. Biochim Bio- phys Acta, 1998, 1368(2) :201-215.
8Halder RM, Chappell JL. Vitiligo update [ J ]. Semin Cu- tan Med Surg, 2009, 28 (2) : 86-92.
9Do JE,Shin JY, Kim DY, et al. The effect of 308nm exeimer laser on segmental vitiligo: a retrospective study of 80 patients with segmental vitiligo. Photodermatol Photoimmunol Photomed, 2011,27 ( 3 ) : 147- 151.
10Alghamdi KM, Moussa NA, Mandil A, et al. Public perceptions and atti- tudes toward vitiligo[ J]. J Cutan Med Surg,2012,16(5) :334-340.
